5 May – Webinar in connection with year-end report
Alligator hosted a webinar and conference call for investors, analysts, and media, where CEO Søren Bregenholt and CFO Johan Giléus presented and commented on the interim report. The presentation was followed by a Q&A session.
The call will be held in English and a recording can be requested via ir@alligatorbioscience.com.
LATEST NEWS
Alligator announces first patient dosed in investigator-initiated study of intratumoral mitazalimab in early-stage breast cancer
First patient dosed in an investigator-initiated trial evaluating intratumoral mitazalimab, with or without intratumoral nivolumab Study eva …
Alligator Bioscience comments on Henlius update on global phase 3 trial with HLX22
Lund, Sweden – 8 June 2026 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today comments on a recent update regarding patient …
Alligator Bioscience comments on Henlius update on long-term follow-up data for HLX22
Lund, Sweden – 22 May 2026 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today comments on a recent update shared by Shanghai …